A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment WithdrawalGiuseppe Floris, Patrick Schöffski, Agnieszka Woźniak et al.|Clinical Cancer Research|2012Cited by 69
The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor ModelsTomoko Smyth, Nicola G. Wallis, Rachel Donsky et al.|Molecular Cancer Therapeutics|2012Cited by 59
Phosphoinositide 3-Kinase Inhibitors Combined with Imatinib in Patient-Derived Xenograft Models of Gastrointestinal Stromal Tumors: Rationale and EfficacyThomas Van Looy, Patrick Schöffski, Agnieszka Woźniak et al.|Clinical Cancer Research|2014Cited by 50
Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different <i>KIT</i> MutationsYemarshet K. Gebreyohannes, Agnieszka Woźniak|Molecular Cancer Therapeutics|2016Cited by 32
Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing miceSzymon Macioszek, Michał J. Markuszewski, Danuta Dudzik et al.|Translational Oncology|2023Cited by 6